Zentalis Pharmaceuticals's total assets for Q4 2025 were $288.97M, a decrease of -11.70% from the previous quarter. ZNTL total liabilities were $72.76M for the fiscal quarter, a -2.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.